Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FPVGB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,861
Award facts
- Contract value 100% obligated
- $87,860.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $87,860.80, awards AmerisourceBergen Drug Corp the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. The contract, issued by the Defense Logistics Agency (DLA) on November 7, 2025, carries a completion date of November 10, 2025, and utilizes firm fixed pricing with no set-aside designation. The award represents a competitive procurement under an Indefinite Delivery Contract (IDC) vehicle, specifically the DLA Troop Support Medical SPE2DX contract valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing comprehensive medical supply support to federal healthcare systems.
The contract supports the DLA's global pharmaceutical supply mission, which serves military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. XELJANZ XR is a branded immunosuppressant medication used in the treatment of rheumatoid arthritis and other autoimmune conditions. As a child delivery order under the larger SPE2DX pharmaceutical prime vendor vehicle, this award demonstrates AmerisourceBergen's continued role as a critical vendor for federal medical procurement. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the strategic suppliers supporting federal military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FPVGB?
SPE2DB26FPVGB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FPVGB worth?
The government has obligated $87,861 on SPE2DB26FPVGB.
Is contract SPE2DB26FPVGB an order under another contract?
Yes. SPE2DB26FPVGB is a delivery order under SPE2DB25D3003, an indefinite delivery contract.
Was contract SPE2DB26FPVGB competed?
The extent of competition for SPE2DB26FPVGB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award